Subscribe to our news feed
A question?
13-03-2025
NOTICE OF ANNUAL GENERAL MEETING IN GETINGE AB (PUBL)
The shareholders of Getinge AB (publ), corporate ID No. 556408-5032, (“Getinge”) are hereby invited to attend the Annual General Meeting (the “AGM”) on Tuesday, April 22, 2025 at 3.00 p.m. CEST, in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. Entrance registration starts at 2.00 p.m. CEST. A lighter snack will be served after the AGM. The Board of Directors of Getinge has decided that the shareholders shall be able to exercise their voting right the AGM by postal voting in accordance with the regulations in Getinge’s Articles of Association, as further described below.
11-03-2025
Getinge’s Nomination Committee proposes Ulrika Dellby as new Board member
The Nomination Committee of Getinge AB (publ) proposes that Ulrika Dellby is elected as new Board member at the Annual General Meeting (“AGM”) on April 22, 2025. Further, the Nomination Committee proposes re-election of all current Board members.
27-02-2025
Getinge’s new DPTE®-FLEX Alpha port enables gloveless component transfer, minimizing human intervention and contamination risks in pharmaceutical production
Getinge is introducing its new DPTE®-FLEX, a manual, externally openable port. This new port enhances safety, efficiency, and compliance in pharmaceutical manufacturing by allowing secure, gloveless transfers, which reduces human intervention and contamination risks. This complements their existing products, the DPTE®-XS and DPTE®-EXO Alpha ports.
28-01-2025
Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins
“In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all regions”, says Mattias Perjos, CEO of Getinge.
14-01-2025
Getinge invites fund managers, analysts, and media to Year-End Report 2024 conference call
Getinge will issue its Year-End Report 2024 on January 28, 2025, at 08:00 a.m. CET, followed by a conference call at 10:00 a.m. CET, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.
19-12-2024
Getinge and 908 Devices partner to enhance bioreactor capabilities for continuous monitoring of key cell culture parameters
Today, Getinge and 908 Devices announce their collaboration to integrate Getinge’s bioreactors with 908 Devices’ MAVEN for automated control of glucose and lactate levels in cell cultures. The combined solution will help scientists measure critical process parameters in bioreactors, offering continuous, real-time analysis without the need for manual sampling.
Press Contacts
Alexandra Holland
EVP Brand & Communication
Phone: +1 908 930 8661
Caroline Örmgård
Head of Public & Media Relations
Phone: +46 10 335 0041
Contact us online
Click below to fill in the appropriate form. We will be in touch shortly.
Are you looking for
Image Gallery
Diverse picture format made available for press article purpose
About us
All you need to know about Getinge a one glance
Urgent Medical Device Correction
Voluntary Urgent Medical Device Field Correction for the CARDIOSAVE intra-aortic balloon pump (IABP)
Don't miss anything
Click on the icons and follow us!